Latest Stories
3 Reasons PVH is Risky and 1 Stock to Buy Instead
What a brutal six months it’s been for PVH. The stock has dropped 20.4% and now trades at $68.41, rattling many shareholders. This may have investors wondering how to approach the situation.
PulteGroup (PHM): Buy, Sell, or Hold Post Q4 Earnings?
PulteGroup currently trades at $136.99 per share and has shown little upside over the past six months, posting a middling return of 3.7%.
Griffon (GFF): Buy, Sell, or Hold Post Q4 Earnings?
Griffon trades at $85.22 and has moved in lockstep with the market. Its shares have returned 12% over the last six months while the S&P 500 has gained 7.7%.
3 Reasons to Avoid CRMT and 1 Stock to Buy Instead
Shareholders of America's Car-Mart would probably like to forget the past six months even happened. The stock dropped 55.6% and now trades at $20. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
2 Reasons to Like ABT and 1 to Stay Skeptical
Over the last six months, Abbott Laboratories’s shares have sunk to $116.31, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 7.7% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell WOOF and 1 Stock to Buy Instead
Petco’s stock price has taken a beating over the past six months, shedding 29.8% of its value and falling to $2.54 per share. This might have investors contemplating their next move.
3 Reasons ABM is Risky and 1 Stock to Buy Instead
Over the past six months, ABM’s shares (currently trading at $44.41) have posted a disappointing 8.9% loss, well below the S&P 500’s 7.7% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons SNDR is Risky and 1 Stock to Buy Instead
Over the past six months, Schneider has been a great trade, beating the S&P 500 by 8.4%. Its stock price has climbed to $28.35, representing a healthy 16.1% increase. This run-up might have investors contemplating their next move.
3 Reasons We’re Fans of McKesson (MCK)
What a fantastic six months it’s been for McKesson. Shares of the company have skyrocketed 42.9%, setting a new 52-week high of $988.29. This performance may have investors wondering how to approach the situation.
3 Reasons to Sell CLX and 1 Stock to Buy Instead
Clorox trades at $126.98 per share and has stayed right on track with the overall market, gaining 5.8% over the last six months. At the same time, the S&P 500 has returned 7.7%.